Shopping Cart 0
Cart Subtotal
USD 0

Precipio Inc (TBIO) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Precipio Inc (Precipio), formerly Transgenomic Inc, is a developer and provider of diagnostic tools and services. The company advances personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. It offers ICEme Kits, which finds applications for mutation specific, disease specific and gene specific panels. Precipio uses ICE COLD-PCR, a sensitivity platform technology, which enables adoption of personalized, precision medicine in cancer and other diseases. Transgenomic'S MX-ICP is an amplification technology that suppresses normal DNA and thereby enables the selective amplification of mutations. Its MX-ICP works on sample types that contain DNA, including tissue, blood, urine and saliva or sputum. It operates through its research and development facility located in Omaha, Nebraska, the US. Precipio is headquartered in Omaha, Nebraska, the US.

Precipio Inc (TBIO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Precipio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Precipio Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Precipio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Precipio Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Precipio Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Precipio Inc, Medical Equipment, Deal Details 11

Asset Purchase 11

Transgenomic Completes Acquisition Of Rights To Scoliscore AIS Prognostic Test From Axial Biotech For USD 4 Million 11

Partnerships 13

LifeLabs Enters into Licensing Agreement with Transgenomic 13

University of Melbourne Enters into Licensing Agreement with Transgenomic 14

Transgenomic Expands Licensing Agreement with Dana-Farber Cancer Institute for Multiplexed Ice cold-PCR Technlogy 15

Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 16

Precipio Enters into Agreement with Nucleai 17

Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 18

Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 19

Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 20

Transgenomic Expands Licensing Agreement with Exiqon 21

Equity Offering 22

Transgenomic Raises USD1.2 Million in First Tranche of Private Placement of Shares 22

Transgenomic to Raise up to USD3.5 Million in Public Offering of Shares 24

Transgenomic Raises up to USD2.2 Million in Private Placement of Preferred Stock and Warrant 25

Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants 26

Transgenomic Raises USD7 Million in Private Placement of Shares 28

Transgenomic Completes Private Placement Of Shares For USD8.3 Million 29

Transgenomic Completes Private Placement Of Shares For USD 19 Million 30

Debt Offering 31

Transgenomic Raises USD1.2 Million in Private Placement 31

Transgenomic Raises USD0.9 Million in Priavte Placement of Promissory Notes 32

Asset Transactions 33

ADSTEC Acquires Genetic Assays & Platforms Business Unit from Transgenomic 33

Edge Biosystems Acquires Ion Chromatography Product Line and Related Assets from Transgenomic for USD2 Million 34

Integrated DNA Technologies Acquires Rights to Surveyor Mutation Detection Technology and Assets from Transgenomic for up to USD4.25 Million 35

Acquisition 36

Transgenomic Acquires Precipio Diagnostics 36

Precipio Inc-Key Competitors 37

Precipio Inc-Key Employees 38

Precipio Inc-Locations And Subsidiaries 39

Head Office 39

Other Locations & Subsidiaries 39

Recent Developments 40

Financial Announcements 40

Jul 18, 2018: Precipio announces 213% year-over-year revenue growth in preliminary Q2-2018 results 40

Corporate Communications 41

Aug 09, 2018: Precipio Appoints New Board Member to Replace Departing Director 41

Legal and Regulatory 42

Mar 13, 2018: Precipio Settles Lawsuit with Crede Capital 42

Government and Public Interest 43

Apr 03, 2018: Important JAMA Article Underscores Superiority of Precipio's Liquid Biopsy Core Technology 43

Product News 45

Mar 20, 2018: Precipio Integrates Cost Reducing and Fast Turnaround "High Resolution Melt" into Liquid Biopsy Platform 45

Jun 13, 2017: European Patent Office Confirms Grant of New ICE COLD-PCR Patent Exclusively Licensed to Transgenomic 47

Other Significant Developments 48

Apr 11, 2018: Precipio Launches ICE COLD-PCR Research Access Program for Cancer Centers 48

Appendix 50

Methodology 50

About GlobalData 50

Contact Us 50

Disclaimer 50


List Of Figure

List of Figures

Precipio Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Precipio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Precipio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Precipio Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Precipio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Precipio Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Precipio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Precipio Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Precipio Inc, Medical Equipment, Key Facts, 2017 2

Precipio Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Precipio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Precipio Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Precipio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Precipio Inc, Deals By Market, 2012 to YTD 2018 9

Precipio Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Transgenomic Completes Acquisition Of Rights To Scoliscore AIS Prognostic Test From Axial Biotech For USD 4 Million 11

LifeLabs Enters into Licensing Agreement with Transgenomic 13

University of Melbourne Enters into Licensing Agreement with Transgenomic 14

Transgenomic Expands Licensing Agreement with Dana-Farber Cancer Institute for Multiplexed Ice cold-PCR Technlogy 15

Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 16

Precipio Enters into Agreement with Nucleai 17

Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 18

Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 19

Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 20

Transgenomic Expands Licensing Agreement with Exiqon 21

Transgenomic Raises USD1.2 Million in First Tranche of Private Placement of Shares 22

Transgenomic to Raise up to USD3.5 Million in Public Offering of Shares 24

Transgenomic Raises up to USD2.2 Million in Private Placement of Preferred Stock and Warrant 25

Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants 26

Transgenomic Raises USD7 Million in Private Placement of Shares 28

Transgenomic Completes Private Placement Of Shares For USD8.3 Million 29

Transgenomic Completes Private Placement Of Shares For USD 19 Million 30

Transgenomic Raises USD1.2 Million in Private Placement 31

Transgenomic Raises USD0.9 Million in Priavte Placement of Promissory Notes 32

ADSTEC Acquires Genetic Assays & Platforms Business Unit from Transgenomic 33

Edge Biosystems Acquires Ion Chromatography Product Line and Related Assets from Transgenomic for USD2 Million 34

Integrated DNA Technologies Acquires Rights to Surveyor Mutation Detection Technology and Assets from Transgenomic for up to USD4.25 Million 35

Transgenomic Acquires Precipio Diagnostics 36

Precipio Inc, Key Competitors 37

Precipio Inc, Key Employees 38

Precipio Inc, Other Locations 39

Precipio Inc, Subsidiaries 39

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Precipio Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Precipio Inc (Precipio), formerly Transgenomic Inc, is a developer and provider of diagnostic tools and services. The company advances personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. It offers ICEme Kits, which finds applications for mutation specific, disease specific and gene specific panels. Precipio uses ICE COLD-PCR, a sensitivity platform technology, which enables adoption of personalized, precision medicine in cancer and other diseases. Transgenomic'S MX-ICP is an amplification technology that suppresses normal DNA and thereby enables the selective amplification of mutations. Its MX-ICP works on sample types that contain DNA, including tissue, blood, urine and saliva or sputum. It operates through its research and development facility located in Omaha, Nebraska, the US. Precipio is headquartered in Omaha, Nebraska, the US.

Precipio Inc (TBIO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Precipio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Precipio Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Precipio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Precipio Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Precipio Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Precipio Inc, Medical Equipment, Deal Details 11

Asset Purchase 11

Transgenomic Completes Acquisition Of Rights To Scoliscore AIS Prognostic Test From Axial Biotech For USD 4 Million 11

Partnerships 13

LifeLabs Enters into Licensing Agreement with Transgenomic 13

University of Melbourne Enters into Licensing Agreement with Transgenomic 14

Transgenomic Expands Licensing Agreement with Dana-Farber Cancer Institute for Multiplexed Ice cold-PCR Technlogy 15

Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 16

Precipio Enters into Agreement with Nucleai 17

Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 18

Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 19

Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 20

Transgenomic Expands Licensing Agreement with Exiqon 21

Equity Offering 22

Transgenomic Raises USD1.2 Million in First Tranche of Private Placement of Shares 22

Transgenomic to Raise up to USD3.5 Million in Public Offering of Shares 24

Transgenomic Raises up to USD2.2 Million in Private Placement of Preferred Stock and Warrant 25

Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants 26

Transgenomic Raises USD7 Million in Private Placement of Shares 28

Transgenomic Completes Private Placement Of Shares For USD8.3 Million 29

Transgenomic Completes Private Placement Of Shares For USD 19 Million 30

Debt Offering 31

Transgenomic Raises USD1.2 Million in Private Placement 31

Transgenomic Raises USD0.9 Million in Priavte Placement of Promissory Notes 32

Asset Transactions 33

ADSTEC Acquires Genetic Assays & Platforms Business Unit from Transgenomic 33

Edge Biosystems Acquires Ion Chromatography Product Line and Related Assets from Transgenomic for USD2 Million 34

Integrated DNA Technologies Acquires Rights to Surveyor Mutation Detection Technology and Assets from Transgenomic for up to USD4.25 Million 35

Acquisition 36

Transgenomic Acquires Precipio Diagnostics 36

Precipio Inc-Key Competitors 37

Precipio Inc-Key Employees 38

Precipio Inc-Locations And Subsidiaries 39

Head Office 39

Other Locations & Subsidiaries 39

Recent Developments 40

Financial Announcements 40

Jul 18, 2018: Precipio announces 213% year-over-year revenue growth in preliminary Q2-2018 results 40

Corporate Communications 41

Aug 09, 2018: Precipio Appoints New Board Member to Replace Departing Director 41

Legal and Regulatory 42

Mar 13, 2018: Precipio Settles Lawsuit with Crede Capital 42

Government and Public Interest 43

Apr 03, 2018: Important JAMA Article Underscores Superiority of Precipio's Liquid Biopsy Core Technology 43

Product News 45

Mar 20, 2018: Precipio Integrates Cost Reducing and Fast Turnaround "High Resolution Melt" into Liquid Biopsy Platform 45

Jun 13, 2017: European Patent Office Confirms Grant of New ICE COLD-PCR Patent Exclusively Licensed to Transgenomic 47

Other Significant Developments 48

Apr 11, 2018: Precipio Launches ICE COLD-PCR Research Access Program for Cancer Centers 48

Appendix 50

Methodology 50

About GlobalData 50

Contact Us 50

Disclaimer 50


List Of Figure

List of Figures

Precipio Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Precipio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Precipio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Precipio Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Precipio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Precipio Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Precipio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Precipio Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Precipio Inc, Medical Equipment, Key Facts, 2017 2

Precipio Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Precipio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Precipio Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Precipio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Precipio Inc, Deals By Market, 2012 to YTD 2018 9

Precipio Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Transgenomic Completes Acquisition Of Rights To Scoliscore AIS Prognostic Test From Axial Biotech For USD 4 Million 11

LifeLabs Enters into Licensing Agreement with Transgenomic 13

University of Melbourne Enters into Licensing Agreement with Transgenomic 14

Transgenomic Expands Licensing Agreement with Dana-Farber Cancer Institute for Multiplexed Ice cold-PCR Technlogy 15

Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 16

Precipio Enters into Agreement with Nucleai 17

Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 18

Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 19

Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 20

Transgenomic Expands Licensing Agreement with Exiqon 21

Transgenomic Raises USD1.2 Million in First Tranche of Private Placement of Shares 22

Transgenomic to Raise up to USD3.5 Million in Public Offering of Shares 24

Transgenomic Raises up to USD2.2 Million in Private Placement of Preferred Stock and Warrant 25

Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants 26

Transgenomic Raises USD7 Million in Private Placement of Shares 28

Transgenomic Completes Private Placement Of Shares For USD8.3 Million 29

Transgenomic Completes Private Placement Of Shares For USD 19 Million 30

Transgenomic Raises USD1.2 Million in Private Placement 31

Transgenomic Raises USD0.9 Million in Priavte Placement of Promissory Notes 32

ADSTEC Acquires Genetic Assays & Platforms Business Unit from Transgenomic 33

Edge Biosystems Acquires Ion Chromatography Product Line and Related Assets from Transgenomic for USD2 Million 34

Integrated DNA Technologies Acquires Rights to Surveyor Mutation Detection Technology and Assets from Transgenomic for up to USD4.25 Million 35

Transgenomic Acquires Precipio Diagnostics 36

Precipio Inc, Key Competitors 37

Precipio Inc, Key Employees 38

Precipio Inc, Other Locations 39

Precipio Inc, Subsidiaries 39

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Precipio Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.